Bayer AG
XETRA:BAYN
Bayer AG
Change in Working Capital
Bayer AG
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Change in Working Capital
-€3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Change in Working Capital
$7.5m
|
CAGR 3-Years
19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Change in Working Capital
-€896m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-14%
|
|
MPH Health Care AG
XETRA:93M1
|
Change in Working Capital
€12.9m
|
CAGR 3-Years
43%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Change in Working Capital
-€57.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Change in Working Capital
-€571k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Change in Working Capital?
Change in Working Capital
-3.9B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Change in Working Capital amounts to -3.9B EUR.
What is Bayer AG's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
-12%
Over the last year, the Change in Working Capital growth was 6%.